Latest news with #Haffey


National Post
4 days ago
- Business
- National Post
Michael Higgins: A doctor's quest to connect patients with private health-care options
Article content 'There are lots of rules and regulations and they can be a little complex, but we're trying to make that a little less veiled in secrecy and trying to make it more open and transparent,' said Haffey. Article content Surgeons on the platform will focus on elective procedures — the surgeries that the health-care system deems non-urgent, but can severely impact a person's life. Article content 'The most commonly associated procedures are going to be things like joint replacement, hip and shoulders and ankles, gynecological procedures for things like urinary incontinence or pelvic organ prolapse, and non-cancer indications for urologic, ENT, plastics and spinal surgeries,' he said. Article content 'My efforts are mostly targeted at orthopedic surgeons … just because their wait times are ballooning out of control. In some provinces, they're exceeding two years, which is just insane.' Article content Haffey is now including surgeons from other specialties, while avoiding some areas. Article content 'We decided not to focus on cancer or cardiovascular or vascular limb surgeries, first of all because the public system works really well at getting patients care when it is urgent. People might wait a little longer than they're comfortable with, but generally speaking, the public system is good with those life-threatening indications,' he said. Article content The platform has 100 surgeons listed so far, but Haffey hopes to have 500 by the end of the year. Article content 'I wanted to try fixing the system from the inside. Waiting around for policy changes and for the system to fix itself over the past few decades have proven to be an ineffectual way of going about it,' said Haffey. Article content 'I just wanted to build a tool that I wish I had and is something that other primary-care physicians can share with their patients and say, 'Just so you know, there's this free tool and it's something that can help explore your options more.' ' Article content The new platform will probably upset those who see it as another advance of private health care, to the detriment of the universal system. Article content But Haffey sees it as a complement to a system in which, all too often, patients see their conditions spiral out of control before they can even see a surgeon. Article content
Yahoo
6 days ago
- Business
- Yahoo
Accelus Secures New Growth Financing To Support Continued Commercial Expansion and Pipeline Innovation
Industry Veteran Bernie Haffey Appointed Chairman of Accelus Board of Directors PALM BEACH GARDENS, Fla., May 29, 2025--(BUSINESS WIRE)--Accelus ("The Company"), a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the closing of a new equity financing round led by Concord Health Partners, a healthcare-focused investment firm. The capital will support Accelus's continued commercial growth and further development of its differentiated spinal implant technologies. In conjunction with the financing, Accelus has appointed industry veteran Bernie Haffey as Chairman of the Board of Directors. Mr. Haffey, who joined the Accelus board in February 2024, has over 20 years of medtech and healthcare sector experience and will help oversee the Company's next phase of growth. Mr. Haffey founded and serves as President of Haffey&Co, a strategic business management consultancy firm that partners with organizations to optimize performance and execute on strategic goals. He previously served as President & CEO of two successful medtech venture-backed start-ups, Nexis Vision Inc and NDO Surgical, and held executive management roles at Summit Technology, IntraLase Corp Mentor Corp and in Hewlett Packard's Medical Products Group. "The continued support from our partners through this latest equity financing round reinforces our long-term vision to bring meaningful innovation to spine care and expand access to minimally invasive solutions for both surgeons and patients," said Kevin McGann, President and CEO of Accelus. "We are now well positioned to deepen our U.S. market presence and invest in future pipeline innovations that meet the real-world needs of spine surgeons across care settings." Accelus's product portfolio includes the FlareHawk® Interbody Fusion System featuring Adaptive Geometry™ technology, LineSider® Spinal System with modular-cortical screws, and Toro-L® Interbody Fusion System. The company's differentiated implants and instruments support a wide range of minimally invasive techniques suitable for both hospital and ambulatory surgery center (ASC) environments with the goal of preserving patient anatomy, enhancing procedural efficiency, and promoting long-term spinal stability. With more than 32,000 cages implanted in 25 countries, Accelus has established a strong foundation for growth by delivering scalable, surgeon-driven technologies that challenge traditional limitations in spine surgery. The additional funding will enable the company to expand its reach and continue building momentum as it expands its FlareHawk and Toro portfolios. "I am delighted to take this new role as Chairman of the Accelus Board at an important time in the Company's evolution," said Haffey. "I look forward to working with Kevin and the rest of the Accelus team to help drive continued growth and advance the Company's ongoing commitment to building on its best-in-class product offering and stellar reputation." About Accelus Accelus, a worldwide leader in expandable spinal implant technology, is dedicated to enhancing surgical procedures and patient outcomes through innovative spinal solutions. The company's commitment to excellence is evident in its advanced Adaptive Geometry technologies specifically designed for transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), endoscopic-assisted, percutaneous, and lateral spine surgeries. For more information on Accelus and its innovative product portfolio, please visit About Concord Health Partners Concord Health Partners is a healthcare-focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concord has developed a broad network of strategic relationships that contribute expertise and resources and serve as potential commercial partners to portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through technologies and solutions that lower costs, improve quality, and expand access to care. For more information, visit View source version on Contacts Media Contact: Brandy Craig305-676-1679bcraig@


Belfast Telegraph
27-04-2025
- Sport
- Belfast Telegraph
Balmoral off to flyer after wrapping up statement victory over Ulster Transport in Division One debut
Balmoral got their first points on the board on their Private Greens League Haffey Sports Grounds Division One debut, claiming an impressive 36-shot win against Ulster Transport at Belvoir Drive. Having made the transition from the Northern Ireland Bowling Association a few years back, the Belfast club successfully negotiated its way through the ranks to reach the top-flight.